Published in Oncology Business Week, February 22nd, 2009
"The filing of this IND ahead of the scheduled date represents a major corporate achievement for the entire Tigris team," said Edmundo Muniz, M.D., Ph.D., President and Chief Executive Officer of Tigris. "Pending acceptance by the FDA, we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week